bullish
Burning Rock IPO (Part I): Burning a Path to Profitability in Next-Gen Cancer Testing
332 Views09 Jun 2020 17:46
Burning Rock Biotech Ltd (BNR), China’s number one NGS-based cancer therapy selection company has filed for an IPO in the US to raise up to...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Hygeia Healthcare IPO (Part II): Healthy Valuation17 Jun 2020
- Hygeia Healthcare IPO (Part I): A Better Healthcare16 Jun 2020
- Burning Rock IPO Valuation: Warm and Pleasant10 Jun 2020
- Burning Rock IPO (Part I): Burning a Path to Profitability in Next-Gen Cancer Testing09 Jun 2020
- Dada Nexus IPO Valuation: Too Glittery and Overvalued02 Jun 2020
- Dada Nexus IPO: All That Glitters Is Not Gold26 May 2020
- Yeahka IPO: Attractive Business at an Expensive Price Tag21 May 2020
x